LASS2 enhances chemosensitivity of breast cancer by counteracting acidic tumor microenvironment through inhibiting activity of V-ATPase proton pump

Oncogene
S FanW Qin

Abstract

A main obstacle to overcome during the treatment of tumors is drug resistance to chemotherapy; emerging studies indicate that a key factor contributing to this problem is the acidic tumor microenvironment. Here, we found that LASS2 expression was significantly lower in drug-resistant Michigan Cancer Foundation-7/adriamycin (MCF-7/ADR) human breast cancer cells than the drug-sensitive MCF-7 cells, and low expression of LASS2 was associated with poor prognosis in patients with breast cancer. Our results showed that the overexpression of LASS2 in MCF-7/ADR cells increased the chemosensitivity to multiple chemotherapeutic agents, including doxorubicin (Dox), whereas LASS2 knockdown in MCF-7 cells decreased the chemosensitivity. Cell-cycle analysis revealed a corresponding increase in apoptosis in the LASS2-overexpressing cells following Dox exposure, showing that the overexpression of LASS2 increased the susceptibility to Dox cytotoxicity. This effect was mediated by a significant increase in pHe (extracellular pH) and lysosomal pH, and more Dox entered the cells and stayed in the nuclei of cells. In nude mice, the combination of LASS2 overexpression and Dox significantly inhibited the growth of xenografts. Our findings suggest tha...Continue Reading

References

Jan 31, 1992·Biochemical and Biophysical Research Communications·L Ma, M S Center
Jun 11, 1999·British Journal of Cancer·N RaghunandR J Gillies
Dec 11, 1999·Biochimica Et Biophysica Acta·P ThomsenB Norrild
Mar 31, 2000·Pharmacology & Therapeutics·A K LarsenA Skladanowski
Mar 21, 2002·Nature Reviews. Cancer·Michael M GottesmanSusan E Bates
Jul 23, 2002·The Journal of Biological Chemistry·Takayuki TorigoeKimitoshi Kohno
Nov 18, 2004·Journal of the National Cancer Institute·Francesca LucianiStefano Fais
May 9, 2006·American Journal of Physiology. Heart and Circulatory Physiology·J D RojasR Martínez-Zaguilán
May 23, 2006·The Journal of Pharmacology and Experimental Therapeutics·Giovanna PetrangoliniFranco Zunino
Jul 11, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christoph ThussbasNadia Harbeck
Sep 20, 2006·The Journal of Cell Biology·Masahiro Yanagisawa, Panos Z Anastasiadis
Sep 23, 2006·International Journal of Cancer. Journal International Du Cancer·Pei-Jen LouStephen G Bown
Sep 27, 2007·Journal of the National Cancer Institute·Olivier TrédanIan F Tannock
Nov 17, 2007·Cancer Research·Stefano FaisWenxin Qin
Aug 13, 2008·Journal of the National Cancer Institute·Penelope D OttewellIngunn Holen
Sep 4, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C AndreettaF Puglisi
Mar 13, 2009·Carcinogenesis·Susanne SchiffmannSabine Grösch
Nov 17, 2009·Biochemical and Biophysical Research Communications·Racheli Erez-RomanAnthony H Futerman
Jul 24, 2010·Nature Reviews. Cancer·Mads Gyrd-Hansen, Pascal Meier
Oct 12, 2010·Journal of the National Cancer Institute·Anna Maria CalcagnoSuresh V Ambudkar
Nov 10, 2010·The Journal of Clinical Investigation·Isabel Ben-BatallaRoman Perez-Fernandez
Jan 29, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yingjun ZhaoXianghuo He
Jun 21, 2011·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Oct 11, 2011·Molecular Pharmaceutics·Jonathan W WojtkowiakRobert J Gillies

❮ Previous
Next ❯

Citations

Apr 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Samuel A JensenAlexander H Stegh
Sep 12, 2013·Biochimica Et Biophysica Acta·Joo-Won ParkAnthony H Futerman
Aug 25, 2015·Journal of Experimental & Clinical Cancer Research : CR·Bi-Yun WangXi-Chun Hu
Aug 6, 2015·Nanomedicine·Vaibhav MundraRam I Mahato
Jul 31, 2013·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Yongdong NiuWenxin Qin
Jun 27, 2015·Endocrine-related Cancer·Woo-Jae ParkAnthony H Futerman
Dec 3, 2014·Cancer Genetics·Qiang FangJin-hong Pan
May 5, 2016·Journal of Enzyme Inhibition and Medicinal Chemistry·Cristina FedericiStefano Fais
Oct 30, 2016·Journal of Cellular Biochemistry·Yanyan WangYuanlin Zheng
Jan 4, 2018·Metabolites·Elisabetta IessiStefano Fais
Nov 24, 2017·Expert Review of Hematology·Elise AasebøØystein Bruserud
Aug 21, 2018·Journal of Cellular Biochemistry·Shaohua FanYuanlin Zheng
Nov 1, 2018·Medical Oncology·Viviane Palmeira da SilvaFernanda Visioli
Jan 5, 2019·Journal of Cellular Physiology·Yanyan WangShaohua Fan
Sep 16, 2016·Nature Communications·Nicole M AielloBen Z Stanger
Jun 24, 2016·Physiological Reviews·Laura StranskyMichael Forgac
Dec 19, 2019·Expert Opinion on Therapeutic Patents·Enrico Pierluigi Spugnini, Stefano Fais
Feb 27, 2015·Biological Chemistry·Woo-Jae Park, Joo-Won Park
Dec 17, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Fang MeiFei Pei
Jan 24, 2014·Journal of Cellular Biochemistry·Xiaoyan XuFei Pei
Mar 31, 2017·Oncology Letters·Haifeng WangJiansong Wang
Dec 12, 2018·Journal of Cellular Physiology·Ning ShengShaohua Fan
Apr 18, 2014·Journal of Neuro-oncology·Rong-Hu KeJi Xiong
Jul 3, 2020·Cancer Cell International·Milad AshrafizadehSaeed Samarghandian
Jan 11, 2021·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Xuewei ZhangKazuyuki Kitatani
Aug 24, 2019·Progress in Lipid Research·Sebastian BrachtendorfSabine Grösch
Dec 4, 2020·International Journal of Molecular Sciences·Agnieszka Taracha-WisniewskaTomasz Wilanowski
Feb 11, 2021·Molecular Cancer Therapeutics·Bradleigh WhittonSimon J Crabb

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.